Quoin Pharmaceuticals, Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-6.6M | $323.8K |
| FY2021 | — | $657.0K | $7.5M |
| FY2022 | — | $7.4M | $2.9M |
| FY2023 | — | $5.7M | $2.4M |
| FY2024 | — | $9.2M | $3.6M |
| FY2025 | — | $13.1M | $3.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-6.6M | $323.8K |
| FY2021 | — | $657.0K | $7.5M |
| FY2022 | — | $7.4M | $2.9M |
| FY2023 | — | $5.7M | $2.4M |
| FY2024 | — | $9.2M | $3.6M |
| FY2025 | — | $13.1M | $3.8M |